1.420
-0.050
(-3.40%)
At close: January 28 at 12:08:04 PM GMT+8
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-324,863.000
-364,199.000
-292,418.000
-147,492.000
78,825.000
Investing Cash Flow
-174,908.000
-48,001.000
-686,322.000
161,667.000
-215,564.000
Financing Cash Flow
82,708.000
246,278.000
-9,854.000
109,057.000
1,275,381.000
End Cash Position
366,559.000
469,155.000
624,375.000
1,527,204.000
1,430,416.000
Capital Expenditure
-9,474.000
-38,660.000
-16,506.000
-11,135.000
-10,957.000
Issuance of Capital Stock
--
139,137.000
--
132,831.000
1,103,517.000
Issuance of Debt
73,477.000
73,616.000
--
--
--
Repurchase of Capital Stock
-8,972.000
-5,682.000
--
-11,892.000
--
Free Cash Flow
-334,337.000
-402,859.000
-308,924.000
-158,627.000
67,868.000
12/31/2020 - 12/21/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
9995.HK RemeGen Co., Ltd.
13.280
-3.35%
1877.HK JUNSHI BIO
11.000
-2.83%
2257.HK Sirnaomics Ltd.
2.890
+4.33%
3759.HK Pharmaron Beijing Co., Ltd.
14.100
-1.40%
6990.HK Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
159.300
-0.62%
1530.HK 3SBIO
6.010
-3.22%
NYKD.OL Nykode Therapeutics AS
2.6820
+1.98%
6855.HK Ascentage Pharma Group International
33.950
-3.00%
AVBP ArriVent BioPharma, Inc.
28.54
-1.89%
BION.SW BB Biotech AG Ord
40.65
+0.99%